We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Medication guide · Metabolic health and aging research

Metformin: diabetes medicine, insulin resistance, and the longevity question

A decades-old, inexpensive diabetes medicine that is also one of the most studied candidates in aging research, which is not the same as proven.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Metformin is FDA-approved to improve blood sugar control in type 2 diabetes. It is not FDA-approved to slow aging or extend lifespan. Observational studies and animal research generated interest, but no completed randomized trial has shown that metformin prevents age-related disease in people without diabetes. The planned TAME trial was designed to test this.

Boxed warning: lactic acidosis

Metformin can rarely cause lactic acidosis, a serious build-up of acid in the blood. Risk is higher with significant kidney impairment, liver disease, heavy alcohol use, dehydration, serious infection, heart failure, and some imaging contrast procedures. Metformin is contraindicated when eGFR is below 30.

Seek care for unusual muscle pain, trouble breathing, unusual sleepiness, or abdominal pain with nausea and vomiting.

Current label check

The medication-specific claims on this page were checked against these current product labels on 2026-10-03. Longevity claims are labeled unproven and rest on trial literature, not the label.

Source: DailyMed, U.S. National Library of Medicine
Product labelLabel dateBoxed warning on that label
Metformin hydrochloride tablets2026-08-21Lactic acidosis

Established evidence

Approved and off-label uses

The FDA indication is to improve glycemic control in adults and children 10 and older with type 2 diabetes. Clinicians also use it off-label in some people with prediabetes, a use supported by the Diabetes Prevention Program trial, and in polycystic ovary syndrome. Neither longevity nor menopause symptoms are approved uses.

Established evidence

How metformin works

Metformin lowers glucose production in the liver and improves insulin sensitivity. It acts on cellular energy pathways, including AMP-activated protein kinase, and changes the gut microbiome. These broader effects are why researchers have studied it as a possible aging intervention.

Limited human evidence

What the longevity evidence actually shows

Some observational studies reported that people with diabetes taking metformin had outcomes similar to or better than people without diabetes, but later analyses suggested this may reflect differences in who receives metformin rather than a drug effect. Observational data cannot establish cause and effect.

Small human studies have measured biomarkers rather than lifespan. One randomized study in older adults found metformin blunted some muscle gains from strength training, a relevant trade-off for anyone prioritizing muscle in midlife. The TAME (Targeting Aging with Metformin) trial was designed to test whether metformin delays age-related diseases; until such trials report, benefit for healthy people remains unproven.

Established evidence

Common side effects

  • Diarrhea, nausea, gas, and stomach upset, often improving with extended-release forms and taking with meals
  • Metallic taste
  • Vitamin B12 deficiency with long-term use; periodic checks are reasonable
  • Low blood sugar is uncommon alone but possible with other diabetes medicines

Monitoring

Kidney function is checked before starting and periodically. Vitamin B12 may be checked, especially with numbness or anemia. Metformin may be paused around some iodinated contrast imaging procedures.

Evidence summary

Evidence strength by claim
ClaimEvidence level
Lowers blood sugar in type 2 diabetesEstablished, FDA-approved
Reduces progression from prediabetes to diabetesEstablished in randomized trials; off-label
Extends lifespan in healthy humansNot established
Extends lifespan in some animalsMixed preclinical results

Questions to ask a healthcare professional

  • Do I have insulin resistance or prediabetes that changes the picture?
  • Would metformin affect my strength-training goals?
  • Should my B12 and kidney function be checked?

What people ask about Glucophage

Is metformin approved for longevity?+

No. It is FDA approved for type 2 diabetes. Use for aging is unproven and off-label.

Does metformin cause weight loss?+

Some people lose a small amount of weight, but it is not approved as a weight-loss medicine.

Is metformin safe long term?+

It has a long safety record in type 2 diabetes, with important warnings about lactic acidosis and B12 deficiency. Safety in healthy people taking it for aging has not been established.

Does Kindr Health offer metformin?+

This page is educational and does not state or imply availability through Kindr Health.

Education, not a medication offer

Kindr Health does not claim to offer Glucophage on this page. Availability and prescribing are not implied.

SOURCES & REFERENCES

Every clinical claim on this page is sourced.

  1. Metformin prescribing information (current label) (2026) — DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Metformin
  2. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002) — New England Journal of Medicine (Diabetes Prevention Program). pubmed.ncbi.nlm.nih.gov/11832527
  3. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults (2019) — Aging Cell. pubmed.ncbi.nlm.nih.gov/30548390
  4. TAME: Targeting Aging with Metformin (2024) — American Federation for Aging Research. www.afar.org/tame-trial

This resource is educational and does not replace individualized medical advice. Do not start, stop, or change a prescription without guidance from a licensed healthcare professional.